Stelvio Therapeutics Company

Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma.
Technology: Personalised Medicine
Industry: P4 Medicine
Headquarters: Others
Funding Status: Seed
Investors Number: 2
Estimated Revenue: Less than $1M
Last Funding Type: Seed

Visit Website
https://twitter.com/StelvioOncology
Register and Claim Ownership